Enforcement Report - Week of November 27, 2024
27 Nov 2024 //
FDA
Health Canada Issues Recall of Laboratoire Riva`s Ramipril 5 mg
12 Nov 2020 //
HEALTH CANADA
UC San Diego to assess hypertension drug Ramipril for Covid-19
04 May 2020 //
CLINICALTRIALSARENA
UC San Diego to assess hypertension drug Ramipril for Covid-19
01 May 2020 //
CLINICALTRIALSARENA
Health Canada Issues Recall of Teva Canada Ramipril
01 Feb 2020 //
HEALTH CANADA
Felodipine/ramipril - List of nationally authorised medicinal products
11 Dec 2018 //
EMA
Common Blood Pressure Medication Linked To Increased Risk Of Lung Cancer
27 Oct 2018 //
FORBES
Branded heart, diabetes drugs much costlier than generic ones
10 Mar 2017 //
ECONOMIC TIMES
Improving solubility: MilliporeSigma opens dedicated meglumine site
19 Jan 2017 //
IN PHARMATECHNOLOGIST
DoP Rejects Review Application by Lupin Against Fixation of Ceiling Price
26 Oct 2016 //
PHARMABIZ
Anvisa suspends distribution of Sanofi –Aventis’ Antihypertensive Drug
08 Apr 2015 //
ANVISA